DexCom Inc (BSP:D1EX34)
R$ 9.65 0 (0%) Market Cap: 188.46 Bil Enterprise Value: 189.05 Bil PE Ratio: 47.26 PB Ratio: 15.58 GF Score: 74/100

DexCom Inc at Morgan Stanley Healthcare Conference Transcript

Sep 09, 2019 / 01:55PM GMT
Unidentified Analyst

It's my pleasure to have this year DexCom and their Chief Financial Officer and EVP, Quentin Blackford. We're going to dispense with preamble and go straight into Q&A. Before I begin, make sure you go to the research disclosure website at morganstanley.com and find fun facts and figures about me.

Questions & Answers

Unidentified Analyst

So Quentin, I want to start with, frankly, guidance. Everyone's favorite topic here. So a couple of things here. U.S. and ex-U. S. With U.S., I'm going to spend less time on just because you've been sort of consistently conservative these last 4 to 6 quarters. But I want to talk about the ex-U. S. market, just one thing that stuck out to us off the second quarter. There were some order dynamics that impacted maybe -- the number was kind of not as good as we were expecting, maybe 3 million to 5 million was order dynamics. But maybe just help us understand what happened here in the second quarter? Is it a -- any indication of underlying trends or sort of more of a one-off dynamic in the second quarter?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot